<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BIIB
Biogen
$
()


  • Biogen price target lowered by $15 at Barclays, here's why

    Today - 04:58am
  • What You Missed On Wall Street On Wednesday

    4/24/2024 - 16:14pm
  • What You Missed On Wall Street This Morning

    4/24/2024 - 13:04pm
  • Fly Intel: Pre-market Movers

    4/24/2024 - 08:50am
  • Biogen backs FY24 adjusted EPS view of $15.00-$16.00, consensus $15.46

    4/24/2024 - 06:50am
  • Biogen reports Q1 adjusted EPS $3.67, consensus $3.44

    4/24/2024 - 06:48am
  • Notable companies reporting before tomorrow's open

    4/23/2024 - 20:25pm
  • Notable companies reporting before tomorrow's open

    4/23/2024 - 13:18pm
  • Biogen price target lowered by $20 at Oppenheimer, here's why

    4/19/2024 - 07:43am
  • Biogen price target lowered by $20 at BofA, here's why

    4/12/2024 - 06:56am
  • Biogen price target lowered by $30 at JPMorgan, here's why

    4/11/2024 - 06:01am
  • Biogen price target lowered by $15 at Barclays, here's why

    4/3/2024 - 17:39pm
  • Biogen delayed Leqembi submission brings questions, says Barclays

    4/1/2024 - 05:33am
  • Eisai, Biogen announce sBLA submission for monthly LEQEMBI IV maintenance dosing

    3/31/2024 - 19:48pm
  • Eisai says CHMP oral explanation for lecanemab rescheduled

    3/22/2024 - 09:23am
dynamic_feed Breaking News